Gordon Stewart
26Patents
10h-index
52Co-inventors
78Inventor score
Filing activity: Apr 9, 1992 → Nov 25, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7396539B1 | Stent coatings with engineered drug release rate | Human Necessities | 53 | Expired |
| US5498525A | Methods for rapid microbial detection | Chemistry; Metallurgy | 41 | Expired |
| US7638156B1 | Apparatus and method for selectively coating a medical article | Emerging Cross-Sectional Technologies | 37 | Active |
| US5593827A | Autoinducer | Chemistry; Metallurgy | 33 | Expired |
| US5948649A | Method for identifying nucleic acid sequences from different biological sources through amplification of the same | Chemistry; Metallurgy | 26 | Expired |
| US5776974A | Immunosuppressant compounds | Human Necessities | 20 | Expired |
| US5840308A | Antiviral or antifungal composition comprising an extract of pomegranate rind or other plants and method of use | Human Necessities | 19 | Expired |
| US5723330A | Genetically engineered reporter bacteria for the detection of bacteriophage | Chemistry; Metallurgy | 18 | Expired |
| US8715707B2 | Freeze-thaw method for modifying stent coating | Human Necessities | 15 | Active |
| US8815274B2 | Poly(ester amides) for the control of agent-release from polymeric compositions | Human Necessities | 14 | Active |
| US8241653B1 | Piezoelectricity modulated release rate of drug from a coating | Human Necessities | 6 | Active |
| US8100855B2 | Methods and devices for eluting agents to a vessel | Human Necessities | 6 | Active |
| US5969158A | Method of treating allergic disease | Human Necessities | 6 | Expired |
| US8246973B2 | Freeze-thaw method for modifying stent coating | Human Necessities | 5 | Active |
| US8435550B2 | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device | Human Necessities | 4 | Active |
| US8173199B2 | 40-O-(2-hydroxy)ethyl-rapamycin coated stent | Human Necessities | 3 | Active |
| US5827678A | Assay reagent comprising killed bacterial cells which retain functional metabolic activity | Chemistry; Metallurgy | 2 | Expired |
| US8586069B2 | Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders | Human Necessities | 2 | Active |
| US6187316A | Antiviral or antifungal composition and method | Human Necessities | 1 | Expired |
| US9636486B2 | Methods and devices for eluting agents to a vessel | Human Necessities | 1 | Active |
| US8017140B2 | Drug-delivery stent formulations for restenosis and vulnerable plaque | Human Necessities | 0 | Active |
| US8562669B2 | Methods of application of coatings composed of hydrophobic, high glass transition polymers with tunable drug release rates | Human Necessities | 0 | Active |
| US8961588B2 | Method of coating a stent with a release polymer for 40-O-(2-hydroxy)ethyl-rapamycin | Human Necessities | 0 | Active |
| US8936780B2 | Stimuli responsive polyester amide particles | Emerging Cross-Sectional Technologies | 0 | Active |
| US9216027B2 | Methods and devices for eluting agents to a vessel | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.